Redox regulation of neurovascular function by acetazolamide: Complementary insight into mechanisms underlying high-altitude acclimatisation

Journal of Physiology

Volumn 590, Issue 15, 2012, Pages 3627-3628

  Bailey, Damian M ^a,b   Brugniaux, Julien V ^a   Pietri, Sylvia ^b   Culcasi, Marcel ^b   Swenson, Erik R ^c  

^a UNIVERSITY OF GLAMORGAN   (United Kingdom)

^b AIX MARSEILLE UNIV   (France)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE; HYDROXYL RADICAL; HYPOXIA INDUCIBLE FACTOR 1; NITRIC OXIDE; THIADIAZOLE DERIVATIVE;

ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; BRAIN BLOOD FLOW; BRAIN FUNCTION; BREATHING PATTERN; CARBON DIOXIDE TENSION; CAROTID BODY; CELL DAMAGE; CEREBROSPINAL FLUID; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ELECTRON TRANSPORT; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HYDROGEN BOND; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; LETTER; LIPID PEROXIDATION; NEUROLOGIC DISEASE; OXIDATION REDUCTION STATE; OXYGENATION; PRIORITY JOURNAL; RADIATION PROTECTION; REGULATORY MECHANISM; SLEEP DISORDERED BREATHING;

EID: 84864291207     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.238071     Document Type: Letter

References (11)

1. Bailey DM, Bartsch P, Knauth M & Baumgartner RW (2009). Emerging concepts in acute mountain sickness and high-altitude cerebral edema: from the molecular to the morphological. Cell Mol Life Sci 66, 3583-3594.
2. Bailey DM & Davies B (2001). Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude. High Alt Med Biol 2, 21-29.
3. Bailey DM, Dehnert C, Luks AM, Menold E, Castell C, Schendler G et al. (2010). High-altitude pulmonary hypertension is associated with a free radical-mediated reduction in pulmonary nitric oxide bioavailability. J Physiol 588, 4837-4847.
4. Cressier D, Prouillac C, Hernandez P, Amourette C, Diserbo M, Lion C & Rima G (2009). Synthesis, antioxidant properties and radioprotective effects of new benzothiazoles and thiadiazoles. Bioorg Med Chem 17, 5275-5284.
5. Fan JL, Burgess KR, Thomas KN, Lucas SJ, Cotter JD, Kayser B, Peebles KC & Ainslie PN (2012). Effects of acetazolamide on cerebrovascular function and breathing stability at 5050 m. J Physiol 590, 1213-1225.
6. Hohne C, Pickerodt PA, Francis RC, Boemke W & Swenson ER (2007). Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition. Am J Physiol Lung Cell Mol Physiol 292, L178-L184.
7. Prabhakar NR & Semenza GL (2012). Gaseous messengers in oxygen sensing. J Mol Med (Berl) 90, 265-272.
8. Prouillac C, Vicendo P, Garrigues JC, Poteau R & Rima G (2009). Evaluation of new thiadiazoles and benzothiazoles as potential radioprotectors: free radical scavenging activity in vitro and theoretical studies (QSAR, DFT). Free Radic Biol Med 46, 1139-1148.
9. Teppema LJ, Bijl H, Romberg RR & Dahan A (2006). Antioxidants reverse depression of the hypoxic ventilatory response by acetazolamide in man. J Physiol 572, 849-856.
10. Toda N, Ayajiki K & Okamura T (2009). Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev 61, 62-97.
11. Vargas F, Hisbeth MV & Rojas JK (1998). Photolysis and photosensitized degradation of the diuretic drug acetazolamide. J Photochem Photobiol A Chem 118, 19-23.